FUSION ANTIBODIES PLC |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.275 GBX | -7.75% |
|
-13.82% | -22.94% |
| Apr. 15 | Fusion Antibodies inks commercial contract for OptiPhage library | AN |
| Apr. 15 | Fusion Antibodies Secures Contract to Set Up OptiPhage Library | MT |
Chart calendar Fusion Antibodies plc
07794fca37c708.zS8SsdpE6_grvjiSWmjJws7a0aVZ93T7IwiYX5oQyRE.gVtLy5UevpV7-ErkaTq_-rytoeosgyWNSGnIMc0h_n2ISVfovyeKmkjbAA~160c874a5a5cca13b446b36ef3bb4cf9
Upcoming events on Fusion Antibodies plc
No events available
Past events on Fusion Antibodies plc
| 2024-03-05 05:00 am | Shareholder Meeting |
| 2024-01-10 | Proactive One2One Virtual Investor Forum |
| 2023-12-07 06:00 am | Q2 2024 Earnings Call |
| 2023-12-04 02:00 am | Q2 2024 Earnings Release |
| 2023-10-26 | Annual General Meeting |
| 2023-10-04 06:00 am | Q4 2023 Earnings Call |
| 2023-09-29 02:00 am | Q4 2023 Earnings Release |
| 2023-06-08 05:00 am | Shareholder Meeting |
| 2023-03-06 02:00 am | Q4 2023 Sales and Revenue Release - Trading Update |
| 2022-12-09 05:00 am | Interim 2023 Earnings Call |
| 2022-12-05 02:00 am | Interim 2023 Earnings Release |
| 2022-09-22 | Annual General Meeting |
| 2022-09-01 06:00 am | FY 2022 Earnings Call |
| 2022-08-23 02:00 am | FY 2022 Earnings Release |
| 2022-05-06 02:00 am | FY 2022 Sales and Revenue Release - Trading Update |
| 2021-12-09 06:00 am | Interim 2022 Earnings Call |
| 2021-12-06 02:00 am | Interim 2022 Earnings Release |
| 2021-09-24 06:00 am | Annual General Meeting |
| 2021-08-09 | FY 2021 Earnings Release |
| 2021-06-08 | Bio Korea Conference |
Annual results
| Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 2,18 | 3,90 3,80 2.5% | 0,00 | 0,00 | 2,90 2,85 1.79% | 1,15 |
|
EBITDA Million GBP | Released Forecast Spread | -1,10 | -0,44 -0,45 2.23% | 0,00 | 0,00 | -2,49 -2,35 -5.61% | -1,47 |
|
EBIT Million GBP | Released Forecast Spread | 0,00 | -1,06 -1,05 -0.86% | 0,00 | 0,00 | -2,86 -2,75 -4.08% | -1,72 |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | 0,00 | -1,07 -1,05 -2.58% | 0,00 | 0,00 | -2,86 -2,76 -3.59% | -1,74 |
|
Net income Million GBP | Released Forecast Spread | 0,00 | -0,70 -0,87 19.52% | -2,90 | -1,20 | -2,60 -2,46 -5.57% | -1,59 |
|
EPS GBP | Released Forecast Spread | -0,06 | -0,03 -0,04 17.95% | -0,11 | -0,05 | -0,10 -0,10 -5.26% | -0,03 |
| Announcement Date | 02/07/19 | 19/08/20 | 10/08/21 | 23/08/22 | 29/09/23 | - |
Quarterly results
| Fiscal Period | Marzo | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 1,04 0,99 5.17% | 0,54 0,54 0% | 0,61 | |
|
EBITDA Million GBP | Released Forecast Spread | -1,48 -1,35 -9.81% | -1,23 -0,82 -49.94% | -0,24 | |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | -1,60 -1,50 -6.47% | -1,42 -0,95 -49.63% | ||
|
Net income Million GBP | Released Forecast Spread | -1,12 | |||
|
EPS GBP | Released Forecast Spread | -0,04 | |||
| Announcement Date | 05/12/22 | 29/09/23 | 04/12/23 | - |
| 2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-05-01 06:30 am | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 2024-05-01 06:30 am | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 2024-05-01 07:00 am | ALKERMES PLC: Q1 2024 Earnings Release |
| 2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 2024-05-01 | CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for Fusion Antibodies plc
| Today | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 2024-04-29 04:05 pm | QIAGEN N.V.: Q1 2024 Earnings Release |
| 2024-04-29 04:01 pm | MORPHOSYS AG: Q1 2024 Earnings Release |
| 2024-04-28 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-28 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release |
| 2024-04-27 | SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release |
| 2024-04-26 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-26 01:00 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 2024-04-25 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- FAB Stock
- Calendar Fusion Antibodies plc
